Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin’s lymphoma patients treated with chemotherapy: a randomised tria
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin’s lymphoma patients treated with chemotherapy: a randomised tria
Yihui Wen, Yangzhi Zhao, Junna Li, Jia Li et al.
Journal
Translational Cancer Research
Topics
Neutropenia and Cancer Infections
article
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin’s lymphoma patients treated with chemotherapy: a randomised tria
Yihui Wen, Yangzhi Zhao, Junna Li, Jia Li, Bowen Wang, Panpan Yan, Wei Guo, Luming Cao, Ou Bai
article en
Abstract
No abstract available for this paper.
Publication Tag
Translational Cancer ResearchVol. 14(12)
Institutions
Jilin University (CN), First Hospital of Jilin University (CN)